AI in Clinical Trials: A CEO’s Perspective
We’re thrilled to see our CEO and co-founder, Scott Chetham, featured on the Life Sciences DNA Podcast with Amar Drawid. In this conversation, Scott unpacks how AI is no longer a distant promise—it’s a present force transforming clinical development.
From the front lines of protocol design to the strategic core of biotech innovation, Scott explores:
- How AI enhances patient selection
- Drives smarter feasibility assessments
- Powers intelligent protocol writing
These are the critical leverage points where Faro Health is driving impact—accelerating timelines, improving precision, and lowering costs across the drug development lifecycle.
At Faro, we believe that AI is the connective tissue between science and speed. It’s enabling a new era of clinical trials—designed with insight, not just hindsight.
Tune into the full episode to hear Scott’s vision: https://shorturl.at/IhHUu
Spotify: https://shorturl.at/p9lOh
